Safety, tolerability, pharmacokinetics, and efficacy of SHR-A1811, an antibody- drug conjugate, in patients with advanced HER2-mutant non-small cell lung cancer (NSCLC): a multicenter, open-label, phase 1/2 study

被引：2
|
作者：
Lu, Shun
Jian, Hong
Hong, Wei
Song, Zhengbo
Yang, Nong
Hu, Sheng
Liang, Zibin
Wang, Yongsheng
Wang, Yan
Peng, Min
Yu, Yan
Li, You
Shuang, Jiapeng
Zhao, Kaijing
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 08期
关键词：
D O I：
10.1158/1538-7445.AM2023-CT204
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CT204
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Motesanib or bevacizumab in combination with paclitaxel and carboplatin in patients with advanced nonsquamous non-small cell lung cancer (NSCLC): interim results from a randomized, open-label, phase 2 study
    Blumenschein, G., Jr.
    Schwartzberg, L. S.
    Menon, H.
    Mok, T. S. K.
    Stephenson, J. J.
    Beck, J. T.
    Lakshmaiah, K.
    Kracht, K.
    Sikorski, R.
    Kabbinavar, F.
    EJC SUPPLEMENTS, 2009, 7 (02): : 555 - 555
  • [32] Efficacy and safety of sunitinib in a multicenter phase II trial of previously treated, advanced non-small cell lung cancer (NSCLC)
    Socinski, Mark A.
    Novello, Silvia
    Sanchez, Jose M.
    Brahmer, Julie
    Govindan, Ramaswamy
    Belani, Chandra P.
    Atkins, James N.
    Gillenwater, Heidi H.
    Palleres, C.
    Chao, Richard C.
    ANNALS OF ONCOLOGY, 2006, 17 : 218 - 218
  • [33] A multicenter, open-label, phase II trial of S-1 plus carboplatin in advanced non-small cell lung cancer patients with interstitial lung disease
    Hanibuchi, Masaki
    Kakiuchi, Soji
    Atagi, Shinji
    Ogushi, Fumitaka
    Shimizu, Eiji
    Haku, Takashi
    Toyoda, Yuko
    Azuma, Masahiko
    Kondo, Mayo
    Kawano, Hiroshi
    Otsuka, Kenji
    Sakaguchi, Satoshi
    Nokihara, Hiroshi
    Goto, Hisatsugu
    Nishioka, Yasuhiko
    LUNG CANCER, 2018, 125 : 93 - 99
  • [34] A Multicenter, Open-Label, Phase II Trial of S-1 Plus Carboplatin in Advanced Non-Small Cell Lung Cancer Patients with Interstitial Lung Disease
    Hanibuchi, M.
    Kakiuchi, S.
    Atagi, S.
    Ogushi, F.
    Shimizu, E.
    Haku, T.
    Toyoda, Y.
    Azuma, M.
    Kondo, M.
    Kawano, H.
    Otsuka, K.
    Sakaguchi, S.
    Nokihara, H.
    Goto, H.
    Nishioka, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S472 - S472
  • [35] Phase 2 study of bortezomib±docetaxel in advanced non-small cell lung cancer (NSCLC)
    Fanucchi, M
    Fossella, F
    Fidias, P
    Natale, R
    Belt, R
    Govindan, R
    Raez, L
    Schiller, J
    Kashala, O
    Kelly, K
    LUNG CANCER, 2005, 49 : S30 - S30
  • [36] Olaparib and durvalumab in patients with relapsed small cell lung cancer (MEDIOLA): An open-label, multicenter, phase 1/2, basket study
    Krebs, Matthew G.
    Delord, Jean-Pierre
    Evans, Thomas R. Jeffry
    De Jonge, Maja
    Kim, Sang-We
    Meurer, Marie
    Postel-Vinay, Sophie
    Lee, Jong-Seok
    Angell, Helen K.
    Rocher-Ros, Vidalba
    Meyer, Kassondra
    Ah-See, Mei-Lin
    Herbolsheimer, Pia
    Lai, Zhongwu
    Nunes, Ana
    Domchek, Susan M.
    LUNG CANCER, 2023, 180
  • [37] Activity of patupilone for the treatment of recurrent or progressive brain metastases in patients (pts) with non-small cell lung cancer (NSCLC): An open-label, multicenter, phase II study
    Abrey, L.
    Wen, P. Y.
    Govindan, R.
    Reimers, H. J.
    Rigas, J. R.
    Robins, H. I.
    de Bedout, S.
    O'Connell, C.
    Li, X.
    Johri, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [38] Pyrotinib Combined with Apatinib for HER2-Mutant Non-Small Cell Lung Cancer: Interim Analysis from a Phase II Clinical Study
    Yang, G.
    Xu, H.
    Xu, F.
    Yang, L.
    Li, H.
    Zhang, S.
    Yang, Y.
    Ai, X.
    Wang, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S672 - S673
  • [39] Trial in progress: A phase Ia/Ib, an open-label, multicenter study of ZL-1310 to evaluate the safety, tolerability, and pharmacokinetics in subjects with small cell lung cancer
    Dowlati, Afshin
    Spira, Alexander
    Shen, Xiaodong
    Fu, Yinjia
    Pan, Yiyuan
    Liu, Linda
    Zhou, Renke
    Wu, Yi-Long
    CANCER RESEARCH, 2024, 84 (07)
  • [40] Efficacy and safety of carboplatin and pemetrexed followed by maintenance with pemetrexed for elderly patients with advanced non-squamous non-small cell lung cancer: A single-arm, open-label, multicenter, phase II study
    Shinoda, Masahiro
    Shinkai, Masaharu
    Hara, Yu
    Tomaru, Kouji
    Manabe, Saki
    Murakami, Syuji
    Saito, Haruhiro
    Kobayashi, Nobuaki
    Miyazawa, Naoki
    Nishikawa, Masanori
    Kaneko, Takeshi
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 (06) : 486 - 494
12345